Amir Reza Hajrasouliha, | |
1160 W Michigan St, Indianapolis, IN 46202-5209 | |
(317) 944-2020 | |
Not Available |
Full Name | Amir Reza Hajrasouliha |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 20 Years |
Location | 1160 W Michigan St, Indianapolis, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083916027 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 01078760A (Indiana) | Secondary |
207WX0107X | Ophthalmology - Retina Specialist | 01078760A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Eskenazi Health | Indianapolis, IN | Hospital |
Indiana University Health | Indianapolis, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Family Physicians, Inc. | 7911992797 | 424 |
News Archive
The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.
A new body to ensure NHS IT helps deliver better care and supports the Government's top priority of putting the interests of patients first was announced today by Health Minister John Hutton.
A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
A six-hour PBS documentary series about the story of cancer, including research and treatment, billed by its producers as one of the most comprehensive of its kind yet made, will premiere nationwide March 30, 31 and April 1 featuring several patient stories and interviews conducted with clinicians and scientists at the Johns Hopkins Kimmel Cancer Center.
› Verified 6 days ago
Entity Name | University Family Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043275787 PECOS PAC ID: 7911992797 Enrollment ID: O20040420000393 |
News Archive
The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.
A new body to ensure NHS IT helps deliver better care and supports the Government's top priority of putting the interests of patients first was announced today by Health Minister John Hutton.
A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
A six-hour PBS documentary series about the story of cancer, including research and treatment, billed by its producers as one of the most comprehensive of its kind yet made, will premiere nationwide March 30, 31 and April 1 featuring several patient stories and interviews conducted with clinicians and scientists at the Johns Hopkins Kimmel Cancer Center.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Amir Reza Hajrasouliha, 250 N Shadeland Ave Ste 130, Indianapolis, IN 46219-4959 Ph: (317) 962-4792 | Amir Reza Hajrasouliha, 1160 W Michigan St, Indianapolis, IN 46202-5209 Ph: (317) 944-2020 |
News Archive
The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.
A new body to ensure NHS IT helps deliver better care and supports the Government's top priority of putting the interests of patients first was announced today by Health Minister John Hutton.
A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
A six-hour PBS documentary series about the story of cancer, including research and treatment, billed by its producers as one of the most comprehensive of its kind yet made, will premiere nationwide March 30, 31 and April 1 featuring several patient stories and interviews conducted with clinicians and scientists at the Johns Hopkins Kimmel Cancer Center.
› Verified 6 days ago
Dr. Frank N. Hrisomalos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1070, Indianapolis, IN 46290 Phone: 317-817-1500 Fax: 317-817-1511 | |
Dr. Sang Hoon Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9002 N Meridian St, Suite 102, Indianapolis, IN 46260 Phone: 317-573-4410 Fax: 317-573-4412 | |
Dr. David V Poer, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8902 N Meridian St, Ste 120, Indianapolis, IN 46260 Phone: 317-582-1118 Fax: 317-582-1116 | |
Scott Hobson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St, Suite 2020, Indianapolis, IN 46290 Phone: 317-817-1976 Fax: 317-817-1737 | |
John Thomas Minturn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Suite #1030, Indianapolis, IN 46290 Phone: 317-817-1586 Fax: 317-817-1399 | |
Keith R Knuth, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 901 E 86th St, Indianapolis, IN 46240 Phone: 317-844-5500 Fax: 317-573-4230 |